Skip to main content
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1976 Aug 21;115(4):309.

Letter: Interferon in serum and cerebrospinal fluid in subacute sclerosing panencephalitis.

J H Joncas, L R Robillard, A Boudreault, M Leyritz, B J McLaughlin
PMCID: PMC1878664  PMID: 953897

Full text

PDF

Page 309

309

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dahl H., Degré M. A micro assay for mouse and human interferon. Acta Pathol Microbiol Scand B Microbiol Immunol. 1972;80(6):863–870. doi: 10.1111/j.0365-5563.1973.tb00012.x. [DOI] [PubMed] [Google Scholar]
  2. De Clercq E., Edy V. G., De Vlieger H., Eeckels R., Desmyter J. Intrathecal administration of interferon in neonatal herpes. J Pediatr. 1975 May;86(5):736–739. doi: 10.1016/s0022-3476(75)80360-x. [DOI] [PubMed] [Google Scholar]
  3. Emödi G., Just M., Grob P. Letter: Circulating interferon after transfer-factor therapy. Lancet. 1973 Dec 15;2(7842):1382–1382. doi: 10.1016/s0140-6736(73)93340-0. [DOI] [PubMed] [Google Scholar]
  4. Joncas J., Geoffroy G., McLaughlin B., Albert G., Lapointe N., David P., Lafontaine R., Granger-Julien M. Subacute sclerosing panencephalitis. Elevated Epstein-Barr virus antibody titers and failure of amantadine therapy. J Neurol Sci. 1974 Apr;21(4):381–390. doi: 10.1016/0022-510x(74)90040-9. [DOI] [PubMed] [Google Scholar]
  5. Sever J. L. Subacute sclerosing panencephalitis treatment. Science. 1972 Jan 14;175(4018):220–223. doi: 10.1126/science.175.4018.220. [DOI] [PubMed] [Google Scholar]
  6. Vandvik B., Froland S. S., Hoyeraal H. M., Stien R., Degré M. Immunological features in a case of subacute sclerosing panencephalitis treated with transfer factor. Scand J Immunol. 1973;2(4):367–374. doi: 10.1111/j.1365-3083.1973.tb02045.x. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES